Trends Health Print Editions Winter 2020

Axon Neuroscience to Launch the First Independent COVID-19 Vaccine

December 16, 2020

The Slovak biotech and pharmaceutical firm is manufacturing a vaccine with a uniquely targeted approach

Independent biotech firm Axon Neuroscience – in neighboring Slovakia – is developing a vaccine for COVID-19 with a uniquely targeted approach.

To access this content, join the community or with your existing account.

Mahnoor Jalal

A Pakistani raised in Vienna, Mahnoor is currently pursuing a degree in Physics. In addition to her scientific inclination, she has an avid interest in media with experience in graphic design and podcast production. She enjoys creative writing and music, particularly singing.

Trends Health Print Editions Winter 2020

Previous articleCoV on December 15 | Holiday & Travel Rules, Vaccine Approval on Dec. 21

Next articleCoV on December 16 | Austria to Receive 900,000 Pfizer/Biontech Vaccine Doses in Q1, Kurz Says

PICK OF THE DAY

Monthly Digital Subscription
€ 4.00 incl. tax / month Buy Now

METROPOLE NEWSLETTER

Join over 5,000 Metropolitans, who already get monthly news updates and event invitations.

Axon Neuroscience to Launch the First Independent COVID-19 Vaccine

RECENT Articles

Aschbacher’s Plagiarism – of Titles and Tragedies

How Viennese Hotels Hold On During the Pandemic

Satisfy Your Sweet Tooth at the Chocolate Museum

Patrick Leigh Fermor’s Vienna

5 Austrian Christmas Traditions Add Charm to the Holiday Season

UK Citizens in Austria – What to Expect After December 31

PICK OF THE DAY

Monthly Digital Subscription

METROPOLE NEWSLETTER

Current Issue

The Lore and Legend Behind the Viennese Kaffeehaus

Meet Christina Meinl, the Great-Granddaughter of Austria’s Coffee Roasting...

What Europe Can Learn From Joe Biden’s Victory

Behind the COVID Vaccine – The Austrian Key to the BioNTech Breakthrough